These individuals were leaner, had a higher insulin sensitivity, a lower risk for impaired glucose tolerance (IGT) (OR 0,44-0,53 in all cohorts, p<=0.009) and lower fasting glucagon levels. This evidence concerns the gene GCG and Impaired glucose tolerance.